Global Hereditary Disease Testing Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Hereditary Disease Testing market size was valued at US$ 1185 million in 2025 and is forecast to a readjusted size of US$ 2600 million by 2032 with a CAGR of 12.0% during review period.
Hereditary disease testing is a medical detection method that analyzes an individual’s genetic material (DNA, RNA, or chromosomes) to identify genetic variations associated with inherited diseases. It helps assess disease risk, diagnose conditions, or guide prevention and treatment.
The global market for hereditary disease testing is experiencing rapid growth, driven by factors such as technological advancements, increased awareness of genetic diseases, and the expansion of personalized medicine.
North America has the largest market share in the global hereditary disease testing market. This is because of its advanced healthcare infrastructure, high - level medical technology, and strong awareness of hereditary diseases among the population. For example, the United States has a large number of leading genetic testing companies and research institutions.
Asia - Pacific is the region with the fastest - growing market. Driven by the continuous increase in healthcare investments and the active promotion of genomic research in countries such as China and India, the market demand is constantly expanding.
This report is a detailed and comprehensive analysis for global Hereditary Disease Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Global Hereditary Disease Testing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Hereditary Disease Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Hereditary Disease Testing market shares of main players, in revenue ($ Million), 2021-2026
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Chapter 2, to profile the top players of Hereditary Disease Testing, with revenue, gross margin, and global market share of Hereditary Disease Testing from 2021 to 2026.
Chapter 3, the Hereditary Disease Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Hereditary Disease Testing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hereditary Disease Testing.
Chapter 13, to describe Hereditary Disease Testing research findings and conclusion.
Hereditary disease testing is a medical detection method that analyzes an individual’s genetic material (DNA, RNA, or chromosomes) to identify genetic variations associated with inherited diseases. It helps assess disease risk, diagnose conditions, or guide prevention and treatment.
The global market for hereditary disease testing is experiencing rapid growth, driven by factors such as technological advancements, increased awareness of genetic diseases, and the expansion of personalized medicine.
North America has the largest market share in the global hereditary disease testing market. This is because of its advanced healthcare infrastructure, high - level medical technology, and strong awareness of hereditary diseases among the population. For example, the United States has a large number of leading genetic testing companies and research institutions.
Asia - Pacific is the region with the fastest - growing market. Driven by the continuous increase in healthcare investments and the active promotion of genomic research in countries such as China and India, the market demand is constantly expanding.
This report is a detailed and comprehensive analysis for global Hereditary Disease Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Hereditary Disease Testing market size and forecasts, in consumption value ($ Million), 2021-2032Global Hereditary Disease Testing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Hereditary Disease Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Hereditary Disease Testing market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Hereditary Disease Testing
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Hereditary Disease Testing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.Market segment by Type
- Hereditary Cancer Testing
- Hereditary Non-cancer Testing
Market segment by Testing Content
- Chromosomal Testing
- Gene Mutation Testing
- Genome/Exome Sequencing
- Carrier Screening Panels
Market segment by Detection Object
- Aldult
- Child
Market segment by Application
- Hospital
- Clinic
- Laboratory
- Others
Market segment by players, this report covers
- Myriad Genetics
- Invitae
- Illumina
- Natera
- Laboratory Corporation of America Holdings
- F. Hoffmann-La Roche
- Quest Diagnostics
- CooperSurgical
- Agilent Technologies
- Thermo Fisher Scientific
- Twist Bioscience
- Sophia Genetics
- Fulgent Genetic
- Medgenome
- CENTOGENE
Market segment by regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
- South America (Brazil, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Hereditary Disease Testing product scope, market overview, market estimation caveats and base year.Chapter 2, to profile the top players of Hereditary Disease Testing, with revenue, gross margin, and global market share of Hereditary Disease Testing from 2021 to 2026.
Chapter 3, the Hereditary Disease Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Hereditary Disease Testing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hereditary Disease Testing.
Chapter 13, to describe Hereditary Disease Testing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hereditary Disease Testing by Type
1.3.1 Overview: Global Hereditary Disease Testing Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Hereditary Disease Testing Consumption Value Market Share by Type in 2025
1.3.3 Hereditary Cancer Testing
1.3.4 Hereditary Non-cancer Testing
1.4 Classification of Hereditary Disease Testing by Testing Content
1.4.1 Overview: Global Hereditary Disease Testing Market Size by Testing Content: 2021 Versus 2025 Versus 2032
1.4.2 Global Hereditary Disease Testing Consumption Value Market Share by Testing Content in 2025
1.4.3 Chromosomal Testing
1.4.4 Gene Mutation Testing
1.4.5 Genome/Exome Sequencing
1.4.6 Carrier Screening Panels
1.5 Classification of Hereditary Disease Testing by Detection Object
1.5.1 Overview: Global Hereditary Disease Testing Market Size by Detection Object: 2021 Versus 2025 Versus 2032
1.5.2 Global Hereditary Disease Testing Consumption Value Market Share by Detection Object in 2025
1.5.3 Aldult
1.5.4 Child
1.6 Global Hereditary Disease Testing Market by Application
1.6.1 Overview: Global Hereditary Disease Testing Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospital
1.6.3 Clinic
1.6.4 Laboratory
1.6.5 Others
1.7 Global Hereditary Disease Testing Market Size & Forecast
1.8 Global Hereditary Disease Testing Market Size and Forecast by Region
1.8.1 Global Hereditary Disease Testing Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Hereditary Disease Testing Market Size by Region, (2021-2032)
1.8.3 North America Hereditary Disease Testing Market Size and Prospect (2021-2032)
1.8.4 Europe Hereditary Disease Testing Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Hereditary Disease Testing Market Size and Prospect (2021-2032)
1.8.6 South America Hereditary Disease Testing Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Hereditary Disease Testing Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Myriad Genetics
2.1.1 Myriad Genetics Details
2.1.2 Myriad Genetics Major Business
2.1.3 Myriad Genetics Hereditary Disease Testing Product and Solutions
2.1.4 Myriad Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Myriad Genetics Recent Developments and Future Plans
2.2 Invitae
2.2.1 Invitae Details
2.2.2 Invitae Major Business
2.2.3 Invitae Hereditary Disease Testing Product and Solutions
2.2.4 Invitae Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Invitae Recent Developments and Future Plans
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Hereditary Disease Testing Product and Solutions
2.3.4 Illumina Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Illumina Recent Developments and Future Plans
2.4 Natera
2.4.1 Natera Details
2.4.2 Natera Major Business
2.4.3 Natera Hereditary Disease Testing Product and Solutions
2.4.4 Natera Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Natera Recent Developments and Future Plans
2.5 Laboratory Corporation of America Holdings
2.5.1 Laboratory Corporation of America Holdings Details
2.5.2 Laboratory Corporation of America Holdings Major Business
2.5.3 Laboratory Corporation of America Holdings Hereditary Disease Testing Product and Solutions
2.5.4 Laboratory Corporation of America Holdings Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.6 F. Hoffmann-La Roche
2.6.1 F. Hoffmann-La Roche Details
2.6.2 F. Hoffmann-La Roche Major Business
2.6.3 F. Hoffmann-La Roche Hereditary Disease Testing Product and Solutions
2.6.4 F. Hoffmann-La Roche Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.7 Quest Diagnostics
2.7.1 Quest Diagnostics Details
2.7.2 Quest Diagnostics Major Business
2.7.3 Quest Diagnostics Hereditary Disease Testing Product and Solutions
2.7.4 Quest Diagnostics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Quest Diagnostics Recent Developments and Future Plans
2.8 CooperSurgical
2.8.1 CooperSurgical Details
2.8.2 CooperSurgical Major Business
2.8.3 CooperSurgical Hereditary Disease Testing Product and Solutions
2.8.4 CooperSurgical Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 CooperSurgical Recent Developments and Future Plans
2.9 Agilent Technologies
2.9.1 Agilent Technologies Details
2.9.2 Agilent Technologies Major Business
2.9.3 Agilent Technologies Hereditary Disease Testing Product and Solutions
2.9.4 Agilent Technologies Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Agilent Technologies Recent Developments and Future Plans
2.10 Thermo Fisher Scientific
2.10.1 Thermo Fisher Scientific Details
2.10.2 Thermo Fisher Scientific Major Business
2.10.3 Thermo Fisher Scientific Hereditary Disease Testing Product and Solutions
2.10.4 Thermo Fisher Scientific Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.11 Twist Bioscience
2.11.1 Twist Bioscience Details
2.11.2 Twist Bioscience Major Business
2.11.3 Twist Bioscience Hereditary Disease Testing Product and Solutions
2.11.4 Twist Bioscience Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Twist Bioscience Recent Developments and Future Plans
2.12 Sophia Genetics
2.12.1 Sophia Genetics Details
2.12.2 Sophia Genetics Major Business
2.12.3 Sophia Genetics Hereditary Disease Testing Product and Solutions
2.12.4 Sophia Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Sophia Genetics Recent Developments and Future Plans
2.13 Fulgent Genetic
2.13.1 Fulgent Genetic Details
2.13.2 Fulgent Genetic Major Business
2.13.3 Fulgent Genetic Hereditary Disease Testing Product and Solutions
2.13.4 Fulgent Genetic Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Fulgent Genetic Recent Developments and Future Plans
2.14 Medgenome
2.14.1 Medgenome Details
2.14.2 Medgenome Major Business
2.14.3 Medgenome Hereditary Disease Testing Product and Solutions
2.14.4 Medgenome Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Medgenome Recent Developments and Future Plans
2.15 CENTOGENE
2.15.1 CENTOGENE Details
2.15.2 CENTOGENE Major Business
2.15.3 CENTOGENE Hereditary Disease Testing Product and Solutions
2.15.4 CENTOGENE Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 CENTOGENE Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Hereditary Disease Testing Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Hereditary Disease Testing by Company Revenue
3.2.2 Top 3 Hereditary Disease Testing Players Market Share in 2025
3.2.3 Top 6 Hereditary Disease Testing Players Market Share in 2025
3.3 Hereditary Disease Testing Market: Overall Company Footprint Analysis
3.3.1 Hereditary Disease Testing Market: Region Footprint
3.3.2 Hereditary Disease Testing Market: Company Product Type Footprint
3.3.3 Hereditary Disease Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Hereditary Disease Testing Consumption Value and Market Share by Type (2021-2026)
4.2 Global Hereditary Disease Testing Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Hereditary Disease Testing Consumption Value Market Share by Application (2021-2026)
5.2 Global Hereditary Disease Testing Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Hereditary Disease Testing Consumption Value by Type (2021-2032)
6.2 North America Hereditary Disease Testing Market Size by Application (2021-2032)
6.3 North America Hereditary Disease Testing Market Size by Country
6.3.1 North America Hereditary Disease Testing Consumption Value by Country (2021-2032)
6.3.2 United States Hereditary Disease Testing Market Size and Forecast (2021-2032)
6.3.3 Canada Hereditary Disease Testing Market Size and Forecast (2021-2032)
6.3.4 Mexico Hereditary Disease Testing Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Hereditary Disease Testing Consumption Value by Type (2021-2032)
7.2 Europe Hereditary Disease Testing Consumption Value by Application (2021-2032)
7.3 Europe Hereditary Disease Testing Market Size by Country
7.3.1 Europe Hereditary Disease Testing Consumption Value by Country (2021-2032)
7.3.2 Germany Hereditary Disease Testing Market Size and Forecast (2021-2032)
7.3.3 France Hereditary Disease Testing Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Hereditary Disease Testing Market Size and Forecast (2021-2032)
7.3.5 Russia Hereditary Disease Testing Market Size and Forecast (2021-2032)
7.3.6 Italy Hereditary Disease Testing Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Hereditary Disease Testing Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Hereditary Disease Testing Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Hereditary Disease Testing Market Size by Region
8.3.1 Asia-Pacific Hereditary Disease Testing Consumption Value by Region (2021-2032)
8.3.2 China Hereditary Disease Testing Market Size and Forecast (2021-2032)
8.3.3 Japan Hereditary Disease Testing Market Size and Forecast (2021-2032)
8.3.4 South Korea Hereditary Disease Testing Market Size and Forecast (2021-2032)
8.3.5 India Hereditary Disease Testing Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Hereditary Disease Testing Market Size and Forecast (2021-2032)
8.3.7 Australia Hereditary Disease Testing Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Hereditary Disease Testing Consumption Value by Type (2021-2032)
9.2 South America Hereditary Disease Testing Consumption Value by Application (2021-2032)
9.3 South America Hereditary Disease Testing Market Size by Country
9.3.1 South America Hereditary Disease Testing Consumption Value by Country (2021-2032)
9.3.2 Brazil Hereditary Disease Testing Market Size and Forecast (2021-2032)
9.3.3 Argentina Hereditary Disease Testing Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Hereditary Disease Testing Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Hereditary Disease Testing Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Hereditary Disease Testing Market Size by Country
10.3.1 Middle East & Africa Hereditary Disease Testing Consumption Value by Country (2021-2032)
10.3.2 Turkey Hereditary Disease Testing Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Hereditary Disease Testing Market Size and Forecast (2021-2032)
10.3.4 UAE Hereditary Disease Testing Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Hereditary Disease Testing Market Drivers
11.2 Hereditary Disease Testing Market Restraints
11.3 Hereditary Disease Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Hereditary Disease Testing Industry Chain
12.2 Hereditary Disease Testing Upstream Analysis
12.3 Hereditary Disease Testing Midstream Analysis
12.4 Hereditary Disease Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hereditary Disease Testing by Type
1.3.1 Overview: Global Hereditary Disease Testing Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Hereditary Disease Testing Consumption Value Market Share by Type in 2025
1.3.3 Hereditary Cancer Testing
1.3.4 Hereditary Non-cancer Testing
1.4 Classification of Hereditary Disease Testing by Testing Content
1.4.1 Overview: Global Hereditary Disease Testing Market Size by Testing Content: 2021 Versus 2025 Versus 2032
1.4.2 Global Hereditary Disease Testing Consumption Value Market Share by Testing Content in 2025
1.4.3 Chromosomal Testing
1.4.4 Gene Mutation Testing
1.4.5 Genome/Exome Sequencing
1.4.6 Carrier Screening Panels
1.5 Classification of Hereditary Disease Testing by Detection Object
1.5.1 Overview: Global Hereditary Disease Testing Market Size by Detection Object: 2021 Versus 2025 Versus 2032
1.5.2 Global Hereditary Disease Testing Consumption Value Market Share by Detection Object in 2025
1.5.3 Aldult
1.5.4 Child
1.6 Global Hereditary Disease Testing Market by Application
1.6.1 Overview: Global Hereditary Disease Testing Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospital
1.6.3 Clinic
1.6.4 Laboratory
1.6.5 Others
1.7 Global Hereditary Disease Testing Market Size & Forecast
1.8 Global Hereditary Disease Testing Market Size and Forecast by Region
1.8.1 Global Hereditary Disease Testing Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Hereditary Disease Testing Market Size by Region, (2021-2032)
1.8.3 North America Hereditary Disease Testing Market Size and Prospect (2021-2032)
1.8.4 Europe Hereditary Disease Testing Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Hereditary Disease Testing Market Size and Prospect (2021-2032)
1.8.6 South America Hereditary Disease Testing Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Hereditary Disease Testing Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Myriad Genetics
2.1.1 Myriad Genetics Details
2.1.2 Myriad Genetics Major Business
2.1.3 Myriad Genetics Hereditary Disease Testing Product and Solutions
2.1.4 Myriad Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Myriad Genetics Recent Developments and Future Plans
2.2 Invitae
2.2.1 Invitae Details
2.2.2 Invitae Major Business
2.2.3 Invitae Hereditary Disease Testing Product and Solutions
2.2.4 Invitae Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Invitae Recent Developments and Future Plans
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Hereditary Disease Testing Product and Solutions
2.3.4 Illumina Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Illumina Recent Developments and Future Plans
2.4 Natera
2.4.1 Natera Details
2.4.2 Natera Major Business
2.4.3 Natera Hereditary Disease Testing Product and Solutions
2.4.4 Natera Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Natera Recent Developments and Future Plans
2.5 Laboratory Corporation of America Holdings
2.5.1 Laboratory Corporation of America Holdings Details
2.5.2 Laboratory Corporation of America Holdings Major Business
2.5.3 Laboratory Corporation of America Holdings Hereditary Disease Testing Product and Solutions
2.5.4 Laboratory Corporation of America Holdings Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.6 F. Hoffmann-La Roche
2.6.1 F. Hoffmann-La Roche Details
2.6.2 F. Hoffmann-La Roche Major Business
2.6.3 F. Hoffmann-La Roche Hereditary Disease Testing Product and Solutions
2.6.4 F. Hoffmann-La Roche Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.7 Quest Diagnostics
2.7.1 Quest Diagnostics Details
2.7.2 Quest Diagnostics Major Business
2.7.3 Quest Diagnostics Hereditary Disease Testing Product and Solutions
2.7.4 Quest Diagnostics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Quest Diagnostics Recent Developments and Future Plans
2.8 CooperSurgical
2.8.1 CooperSurgical Details
2.8.2 CooperSurgical Major Business
2.8.3 CooperSurgical Hereditary Disease Testing Product and Solutions
2.8.4 CooperSurgical Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 CooperSurgical Recent Developments and Future Plans
2.9 Agilent Technologies
2.9.1 Agilent Technologies Details
2.9.2 Agilent Technologies Major Business
2.9.3 Agilent Technologies Hereditary Disease Testing Product and Solutions
2.9.4 Agilent Technologies Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Agilent Technologies Recent Developments and Future Plans
2.10 Thermo Fisher Scientific
2.10.1 Thermo Fisher Scientific Details
2.10.2 Thermo Fisher Scientific Major Business
2.10.3 Thermo Fisher Scientific Hereditary Disease Testing Product and Solutions
2.10.4 Thermo Fisher Scientific Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.11 Twist Bioscience
2.11.1 Twist Bioscience Details
2.11.2 Twist Bioscience Major Business
2.11.3 Twist Bioscience Hereditary Disease Testing Product and Solutions
2.11.4 Twist Bioscience Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Twist Bioscience Recent Developments and Future Plans
2.12 Sophia Genetics
2.12.1 Sophia Genetics Details
2.12.2 Sophia Genetics Major Business
2.12.3 Sophia Genetics Hereditary Disease Testing Product and Solutions
2.12.4 Sophia Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Sophia Genetics Recent Developments and Future Plans
2.13 Fulgent Genetic
2.13.1 Fulgent Genetic Details
2.13.2 Fulgent Genetic Major Business
2.13.3 Fulgent Genetic Hereditary Disease Testing Product and Solutions
2.13.4 Fulgent Genetic Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Fulgent Genetic Recent Developments and Future Plans
2.14 Medgenome
2.14.1 Medgenome Details
2.14.2 Medgenome Major Business
2.14.3 Medgenome Hereditary Disease Testing Product and Solutions
2.14.4 Medgenome Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Medgenome Recent Developments and Future Plans
2.15 CENTOGENE
2.15.1 CENTOGENE Details
2.15.2 CENTOGENE Major Business
2.15.3 CENTOGENE Hereditary Disease Testing Product and Solutions
2.15.4 CENTOGENE Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 CENTOGENE Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Hereditary Disease Testing Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Hereditary Disease Testing by Company Revenue
3.2.2 Top 3 Hereditary Disease Testing Players Market Share in 2025
3.2.3 Top 6 Hereditary Disease Testing Players Market Share in 2025
3.3 Hereditary Disease Testing Market: Overall Company Footprint Analysis
3.3.1 Hereditary Disease Testing Market: Region Footprint
3.3.2 Hereditary Disease Testing Market: Company Product Type Footprint
3.3.3 Hereditary Disease Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Hereditary Disease Testing Consumption Value and Market Share by Type (2021-2026)
4.2 Global Hereditary Disease Testing Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Hereditary Disease Testing Consumption Value Market Share by Application (2021-2026)
5.2 Global Hereditary Disease Testing Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Hereditary Disease Testing Consumption Value by Type (2021-2032)
6.2 North America Hereditary Disease Testing Market Size by Application (2021-2032)
6.3 North America Hereditary Disease Testing Market Size by Country
6.3.1 North America Hereditary Disease Testing Consumption Value by Country (2021-2032)
6.3.2 United States Hereditary Disease Testing Market Size and Forecast (2021-2032)
6.3.3 Canada Hereditary Disease Testing Market Size and Forecast (2021-2032)
6.3.4 Mexico Hereditary Disease Testing Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Hereditary Disease Testing Consumption Value by Type (2021-2032)
7.2 Europe Hereditary Disease Testing Consumption Value by Application (2021-2032)
7.3 Europe Hereditary Disease Testing Market Size by Country
7.3.1 Europe Hereditary Disease Testing Consumption Value by Country (2021-2032)
7.3.2 Germany Hereditary Disease Testing Market Size and Forecast (2021-2032)
7.3.3 France Hereditary Disease Testing Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Hereditary Disease Testing Market Size and Forecast (2021-2032)
7.3.5 Russia Hereditary Disease Testing Market Size and Forecast (2021-2032)
7.3.6 Italy Hereditary Disease Testing Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Hereditary Disease Testing Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Hereditary Disease Testing Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Hereditary Disease Testing Market Size by Region
8.3.1 Asia-Pacific Hereditary Disease Testing Consumption Value by Region (2021-2032)
8.3.2 China Hereditary Disease Testing Market Size and Forecast (2021-2032)
8.3.3 Japan Hereditary Disease Testing Market Size and Forecast (2021-2032)
8.3.4 South Korea Hereditary Disease Testing Market Size and Forecast (2021-2032)
8.3.5 India Hereditary Disease Testing Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Hereditary Disease Testing Market Size and Forecast (2021-2032)
8.3.7 Australia Hereditary Disease Testing Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Hereditary Disease Testing Consumption Value by Type (2021-2032)
9.2 South America Hereditary Disease Testing Consumption Value by Application (2021-2032)
9.3 South America Hereditary Disease Testing Market Size by Country
9.3.1 South America Hereditary Disease Testing Consumption Value by Country (2021-2032)
9.3.2 Brazil Hereditary Disease Testing Market Size and Forecast (2021-2032)
9.3.3 Argentina Hereditary Disease Testing Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Hereditary Disease Testing Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Hereditary Disease Testing Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Hereditary Disease Testing Market Size by Country
10.3.1 Middle East & Africa Hereditary Disease Testing Consumption Value by Country (2021-2032)
10.3.2 Turkey Hereditary Disease Testing Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Hereditary Disease Testing Market Size and Forecast (2021-2032)
10.3.4 UAE Hereditary Disease Testing Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Hereditary Disease Testing Market Drivers
11.2 Hereditary Disease Testing Market Restraints
11.3 Hereditary Disease Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Hereditary Disease Testing Industry Chain
12.2 Hereditary Disease Testing Upstream Analysis
12.3 Hereditary Disease Testing Midstream Analysis
12.4 Hereditary Disease Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Hereditary Disease Testing Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Hereditary Disease Testing Consumption Value by Testing Content, (USD Million), 2021 & 2025 & 2032
Table 3. Global Hereditary Disease Testing Consumption Value by Detection Object, (USD Million), 2021 & 2025 & 2032
Table 4. Global Hereditary Disease Testing Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Hereditary Disease Testing Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Hereditary Disease Testing Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 8. Myriad Genetics Major Business
Table 9. Myriad Genetics Hereditary Disease Testing Product and Solutions
Table 10. Myriad Genetics Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Myriad Genetics Recent Developments and Future Plans
Table 12. Invitae Company Information, Head Office, and Major Competitors
Table 13. Invitae Major Business
Table 14. Invitae Hereditary Disease Testing Product and Solutions
Table 15. Invitae Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Invitae Recent Developments and Future Plans
Table 17. Illumina Company Information, Head Office, and Major Competitors
Table 18. Illumina Major Business
Table 19. Illumina Hereditary Disease Testing Product and Solutions
Table 20. Illumina Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Natera Company Information, Head Office, and Major Competitors
Table 22. Natera Major Business
Table 23. Natera Hereditary Disease Testing Product and Solutions
Table 24. Natera Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Natera Recent Developments and Future Plans
Table 26. Laboratory Corporation of America Holdings Company Information, Head Office, and Major Competitors
Table 27. Laboratory Corporation of America Holdings Major Business
Table 28. Laboratory Corporation of America Holdings Hereditary Disease Testing Product and Solutions
Table 29. Laboratory Corporation of America Holdings Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Laboratory Corporation of America Holdings Recent Developments and Future Plans
Table 31. F. Hoffmann-La Roche Company Information, Head Office, and Major Competitors
Table 32. F. Hoffmann-La Roche Major Business
Table 33. F. Hoffmann-La Roche Hereditary Disease Testing Product and Solutions
Table 34. F. Hoffmann-La Roche Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. F. Hoffmann-La Roche Recent Developments and Future Plans
Table 36. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 37. Quest Diagnostics Major Business
Table 38. Quest Diagnostics Hereditary Disease Testing Product and Solutions
Table 39. Quest Diagnostics Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Quest Diagnostics Recent Developments and Future Plans
Table 41. CooperSurgical Company Information, Head Office, and Major Competitors
Table 42. CooperSurgical Major Business
Table 43. CooperSurgical Hereditary Disease Testing Product and Solutions
Table 44. CooperSurgical Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. CooperSurgical Recent Developments and Future Plans
Table 46. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 47. Agilent Technologies Major Business
Table 48. Agilent Technologies Hereditary Disease Testing Product and Solutions
Table 49. Agilent Technologies Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Agilent Technologies Recent Developments and Future Plans
Table 51. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 52. Thermo Fisher Scientific Major Business
Table 53. Thermo Fisher Scientific Hereditary Disease Testing Product and Solutions
Table 54. Thermo Fisher Scientific Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Thermo Fisher Scientific Recent Developments and Future Plans
Table 56. Twist Bioscience Company Information, Head Office, and Major Competitors
Table 57. Twist Bioscience Major Business
Table 58. Twist Bioscience Hereditary Disease Testing Product and Solutions
Table 59. Twist Bioscience Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Twist Bioscience Recent Developments and Future Plans
Table 61. Sophia Genetics Company Information, Head Office, and Major Competitors
Table 62. Sophia Genetics Major Business
Table 63. Sophia Genetics Hereditary Disease Testing Product and Solutions
Table 64. Sophia Genetics Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Sophia Genetics Recent Developments and Future Plans
Table 66. Fulgent Genetic Company Information, Head Office, and Major Competitors
Table 67. Fulgent Genetic Major Business
Table 68. Fulgent Genetic Hereditary Disease Testing Product and Solutions
Table 69. Fulgent Genetic Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Fulgent Genetic Recent Developments and Future Plans
Table 71. Medgenome Company Information, Head Office, and Major Competitors
Table 72. Medgenome Major Business
Table 73. Medgenome Hereditary Disease Testing Product and Solutions
Table 74. Medgenome Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Medgenome Recent Developments and Future Plans
Table 76. CENTOGENE Company Information, Head Office, and Major Competitors
Table 77. CENTOGENE Major Business
Table 78. CENTOGENE Hereditary Disease Testing Product and Solutions
Table 79. CENTOGENE Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. CENTOGENE Recent Developments and Future Plans
Table 81. Global Hereditary Disease Testing Revenue (USD Million) by Players (2021-2026)
Table 82. Global Hereditary Disease Testing Revenue Share by Players (2021-2026)
Table 83. Breakdown of Hereditary Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 84. Market Position of Players in Hereditary Disease Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 85. Head Office of Key Hereditary Disease Testing Players
Table 86. Hereditary Disease Testing Market: Company Product Type Footprint
Table 87. Hereditary Disease Testing Market: Company Product Application Footprint
Table 88. Hereditary Disease Testing New Market Entrants and Barriers to Market Entry
Table 89. Hereditary Disease Testing Mergers, Acquisition, Agreements, and Collaborations
Table 90. Global Hereditary Disease Testing Consumption Value (USD Million) by Type (2021-2026)
Table 91. Global Hereditary Disease Testing Consumption Value Share by Type (2021-2026)
Table 92. Global Hereditary Disease Testing Consumption Value Forecast by Type (2027-2032)
Table 93. Global Hereditary Disease Testing Consumption Value by Application (2021-2026)
Table 94. Global Hereditary Disease Testing Consumption Value Forecast by Application (2027-2032)
Table 95. North America Hereditary Disease Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 96. North America Hereditary Disease Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 97. North America Hereditary Disease Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 98. North America Hereditary Disease Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 99. North America Hereditary Disease Testing Consumption Value by Country (2021-2026) & (USD Million)
Table 100. North America Hereditary Disease Testing Consumption Value by Country (2027-2032) & (USD Million)
Table 101. Europe Hereditary Disease Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 102. Europe Hereditary Disease Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 103. Europe Hereditary Disease Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 104. Europe Hereditary Disease Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 105. Europe Hereditary Disease Testing Consumption Value by Country (2021-2026) & (USD Million)
Table 106. Europe Hereditary Disease Testing Consumption Value by Country (2027-2032) & (USD Million)
Table 107. Asia-Pacific Hereditary Disease Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 108. Asia-Pacific Hereditary Disease Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 109. Asia-Pacific Hereditary Disease Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 110. Asia-Pacific Hereditary Disease Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 111. Asia-Pacific Hereditary Disease Testing Consumption Value by Region (2021-2026) & (USD Million)
Table 112. Asia-Pacific Hereditary Disease Testing Consumption Value by Region (2027-2032) & (USD Million)
Table 113. South America Hereditary Disease Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 114. South America Hereditary Disease Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 115. South America Hereditary Disease Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 116. South America Hereditary Disease Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 117. South America Hereditary Disease Testing Consumption Value by Country (2021-2026) & (USD Million)
Table 118. South America Hereditary Disease Testing Consumption Value by Country (2027-2032) & (USD Million)
Table 119. Middle East & Africa Hereditary Disease Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 120. Middle East & Africa Hereditary Disease Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 121. Middle East & Africa Hereditary Disease Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 122. Middle East & Africa Hereditary Disease Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 123. Middle East & Africa Hereditary Disease Testing Consumption Value by Country (2021-2026) & (USD Million)
Table 124. Middle East & Africa Hereditary Disease Testing Consumption Value by Country (2027-2032) & (USD Million)
Table 125. Global Key Players of Hereditary Disease Testing Upstream (Raw Materials)
Table 126. Global Hereditary Disease Testing Typical Customers
Table 1. Global Hereditary Disease Testing Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Hereditary Disease Testing Consumption Value by Testing Content, (USD Million), 2021 & 2025 & 2032
Table 3. Global Hereditary Disease Testing Consumption Value by Detection Object, (USD Million), 2021 & 2025 & 2032
Table 4. Global Hereditary Disease Testing Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Hereditary Disease Testing Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Hereditary Disease Testing Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 8. Myriad Genetics Major Business
Table 9. Myriad Genetics Hereditary Disease Testing Product and Solutions
Table 10. Myriad Genetics Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Myriad Genetics Recent Developments and Future Plans
Table 12. Invitae Company Information, Head Office, and Major Competitors
Table 13. Invitae Major Business
Table 14. Invitae Hereditary Disease Testing Product and Solutions
Table 15. Invitae Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Invitae Recent Developments and Future Plans
Table 17. Illumina Company Information, Head Office, and Major Competitors
Table 18. Illumina Major Business
Table 19. Illumina Hereditary Disease Testing Product and Solutions
Table 20. Illumina Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Natera Company Information, Head Office, and Major Competitors
Table 22. Natera Major Business
Table 23. Natera Hereditary Disease Testing Product and Solutions
Table 24. Natera Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Natera Recent Developments and Future Plans
Table 26. Laboratory Corporation of America Holdings Company Information, Head Office, and Major Competitors
Table 27. Laboratory Corporation of America Holdings Major Business
Table 28. Laboratory Corporation of America Holdings Hereditary Disease Testing Product and Solutions
Table 29. Laboratory Corporation of America Holdings Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Laboratory Corporation of America Holdings Recent Developments and Future Plans
Table 31. F. Hoffmann-La Roche Company Information, Head Office, and Major Competitors
Table 32. F. Hoffmann-La Roche Major Business
Table 33. F. Hoffmann-La Roche Hereditary Disease Testing Product and Solutions
Table 34. F. Hoffmann-La Roche Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. F. Hoffmann-La Roche Recent Developments and Future Plans
Table 36. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 37. Quest Diagnostics Major Business
Table 38. Quest Diagnostics Hereditary Disease Testing Product and Solutions
Table 39. Quest Diagnostics Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Quest Diagnostics Recent Developments and Future Plans
Table 41. CooperSurgical Company Information, Head Office, and Major Competitors
Table 42. CooperSurgical Major Business
Table 43. CooperSurgical Hereditary Disease Testing Product and Solutions
Table 44. CooperSurgical Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. CooperSurgical Recent Developments and Future Plans
Table 46. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 47. Agilent Technologies Major Business
Table 48. Agilent Technologies Hereditary Disease Testing Product and Solutions
Table 49. Agilent Technologies Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Agilent Technologies Recent Developments and Future Plans
Table 51. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 52. Thermo Fisher Scientific Major Business
Table 53. Thermo Fisher Scientific Hereditary Disease Testing Product and Solutions
Table 54. Thermo Fisher Scientific Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Thermo Fisher Scientific Recent Developments and Future Plans
Table 56. Twist Bioscience Company Information, Head Office, and Major Competitors
Table 57. Twist Bioscience Major Business
Table 58. Twist Bioscience Hereditary Disease Testing Product and Solutions
Table 59. Twist Bioscience Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Twist Bioscience Recent Developments and Future Plans
Table 61. Sophia Genetics Company Information, Head Office, and Major Competitors
Table 62. Sophia Genetics Major Business
Table 63. Sophia Genetics Hereditary Disease Testing Product and Solutions
Table 64. Sophia Genetics Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Sophia Genetics Recent Developments and Future Plans
Table 66. Fulgent Genetic Company Information, Head Office, and Major Competitors
Table 67. Fulgent Genetic Major Business
Table 68. Fulgent Genetic Hereditary Disease Testing Product and Solutions
Table 69. Fulgent Genetic Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Fulgent Genetic Recent Developments and Future Plans
Table 71. Medgenome Company Information, Head Office, and Major Competitors
Table 72. Medgenome Major Business
Table 73. Medgenome Hereditary Disease Testing Product and Solutions
Table 74. Medgenome Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Medgenome Recent Developments and Future Plans
Table 76. CENTOGENE Company Information, Head Office, and Major Competitors
Table 77. CENTOGENE Major Business
Table 78. CENTOGENE Hereditary Disease Testing Product and Solutions
Table 79. CENTOGENE Hereditary Disease Testing Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. CENTOGENE Recent Developments and Future Plans
Table 81. Global Hereditary Disease Testing Revenue (USD Million) by Players (2021-2026)
Table 82. Global Hereditary Disease Testing Revenue Share by Players (2021-2026)
Table 83. Breakdown of Hereditary Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 84. Market Position of Players in Hereditary Disease Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 85. Head Office of Key Hereditary Disease Testing Players
Table 86. Hereditary Disease Testing Market: Company Product Type Footprint
Table 87. Hereditary Disease Testing Market: Company Product Application Footprint
Table 88. Hereditary Disease Testing New Market Entrants and Barriers to Market Entry
Table 89. Hereditary Disease Testing Mergers, Acquisition, Agreements, and Collaborations
Table 90. Global Hereditary Disease Testing Consumption Value (USD Million) by Type (2021-2026)
Table 91. Global Hereditary Disease Testing Consumption Value Share by Type (2021-2026)
Table 92. Global Hereditary Disease Testing Consumption Value Forecast by Type (2027-2032)
Table 93. Global Hereditary Disease Testing Consumption Value by Application (2021-2026)
Table 94. Global Hereditary Disease Testing Consumption Value Forecast by Application (2027-2032)
Table 95. North America Hereditary Disease Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 96. North America Hereditary Disease Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 97. North America Hereditary Disease Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 98. North America Hereditary Disease Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 99. North America Hereditary Disease Testing Consumption Value by Country (2021-2026) & (USD Million)
Table 100. North America Hereditary Disease Testing Consumption Value by Country (2027-2032) & (USD Million)
Table 101. Europe Hereditary Disease Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 102. Europe Hereditary Disease Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 103. Europe Hereditary Disease Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 104. Europe Hereditary Disease Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 105. Europe Hereditary Disease Testing Consumption Value by Country (2021-2026) & (USD Million)
Table 106. Europe Hereditary Disease Testing Consumption Value by Country (2027-2032) & (USD Million)
Table 107. Asia-Pacific Hereditary Disease Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 108. Asia-Pacific Hereditary Disease Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 109. Asia-Pacific Hereditary Disease Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 110. Asia-Pacific Hereditary Disease Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 111. Asia-Pacific Hereditary Disease Testing Consumption Value by Region (2021-2026) & (USD Million)
Table 112. Asia-Pacific Hereditary Disease Testing Consumption Value by Region (2027-2032) & (USD Million)
Table 113. South America Hereditary Disease Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 114. South America Hereditary Disease Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 115. South America Hereditary Disease Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 116. South America Hereditary Disease Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 117. South America Hereditary Disease Testing Consumption Value by Country (2021-2026) & (USD Million)
Table 118. South America Hereditary Disease Testing Consumption Value by Country (2027-2032) & (USD Million)
Table 119. Middle East & Africa Hereditary Disease Testing Consumption Value by Type (2021-2026) & (USD Million)
Table 120. Middle East & Africa Hereditary Disease Testing Consumption Value by Type (2027-2032) & (USD Million)
Table 121. Middle East & Africa Hereditary Disease Testing Consumption Value by Application (2021-2026) & (USD Million)
Table 122. Middle East & Africa Hereditary Disease Testing Consumption Value by Application (2027-2032) & (USD Million)
Table 123. Middle East & Africa Hereditary Disease Testing Consumption Value by Country (2021-2026) & (USD Million)
Table 124. Middle East & Africa Hereditary Disease Testing Consumption Value by Country (2027-2032) & (USD Million)
Table 125. Global Key Players of Hereditary Disease Testing Upstream (Raw Materials)
Table 126. Global Hereditary Disease Testing Typical Customers
LIST OF FIGURES
Figure 1. Hereditary Disease Testing Picture
Figure 2. Global Hereditary Disease Testing Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Hereditary Disease Testing Consumption Value Market Share by Type in 2025
Figure 4. Hereditary Cancer Testing
Figure 5. Hereditary Non-cancer Testing
Figure 6. Global Hereditary Disease Testing Consumption Value by Testing Content, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Hereditary Disease Testing Consumption Value Market Share by Testing Content in 2025
Figure 8. Chromosomal Testing
Figure 9. Gene Mutation Testing
Figure 10. Genome/Exome Sequencing
Figure 11. Carrier Screening Panels
Figure 12. Global Hereditary Disease Testing Consumption Value by Detection Object, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Hereditary Disease Testing Consumption Value Market Share by Detection Object in 2025
Figure 14. Aldult
Figure 15. Child
Figure 16. Global Hereditary Disease Testing Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Hereditary Disease Testing Consumption Value Market Share by Application in 2025
Figure 18. Hospital Picture
Figure 19. Clinic Picture
Figure 20. Laboratory Picture
Figure 21. Others Picture
Figure 22. Global Hereditary Disease Testing Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Hereditary Disease Testing Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Market Hereditary Disease Testing Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 25. Global Hereditary Disease Testing Consumption Value Market Share by Region (2021-2032)
Figure 26. Global Hereditary Disease Testing Consumption Value Market Share by Region in 2025
Figure 27. North America Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 30. South America Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 32. Company Three Recent Developments and Future Plans
Figure 33. Global Hereditary Disease Testing Revenue Share by Players in 2025
Figure 34. Hereditary Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 35. Market Share of Hereditary Disease Testing by Player Revenue in 2025
Figure 36. Top 3 Hereditary Disease Testing Players Market Share in 2025
Figure 37. Top 6 Hereditary Disease Testing Players Market Share in 2025
Figure 38. Global Hereditary Disease Testing Consumption Value Share by Type (2021-2026)
Figure 39. Global Hereditary Disease Testing Market Share Forecast by Type (2027-2032)
Figure 40. Global Hereditary Disease Testing Consumption Value Share by Application (2021-2026)
Figure 41. Global Hereditary Disease Testing Market Share Forecast by Application (2027-2032)
Figure 42. North America Hereditary Disease Testing Consumption Value Market Share by Type (2021-2032)
Figure 43. North America Hereditary Disease Testing Consumption Value Market Share by Application (2021-2032)
Figure 44. North America Hereditary Disease Testing Consumption Value Market Share by Country (2021-2032)
Figure 45. United States Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Hereditary Disease Testing Consumption Value Market Share by Type (2021-2032)
Figure 49. Europe Hereditary Disease Testing Consumption Value Market Share by Application (2021-2032)
Figure 50. Europe Hereditary Disease Testing Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 52. France Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific Hereditary Disease Testing Consumption Value Market Share by Type (2021-2032)
Figure 57. Asia-Pacific Hereditary Disease Testing Consumption Value Market Share by Application (2021-2032)
Figure 58. Asia-Pacific Hereditary Disease Testing Consumption Value Market Share by Region (2021-2032)
Figure 59. China Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 60. Japan Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 61. South Korea Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 62. India Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 63. Southeast Asia Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 64. Australia Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 65. South America Hereditary Disease Testing Consumption Value Market Share by Type (2021-2032)
Figure 66. South America Hereditary Disease Testing Consumption Value Market Share by Application (2021-2032)
Figure 67. South America Hereditary Disease Testing Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa Hereditary Disease Testing Consumption Value Market Share by Type (2021-2032)
Figure 71. Middle East & Africa Hereditary Disease Testing Consumption Value Market Share by Application (2021-2032)
Figure 72. Middle East & Africa Hereditary Disease Testing Consumption Value Market Share by Country (2021-2032)
Figure 73. Turkey Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 74. Saudi Arabia Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 75. UAE Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 76. Hereditary Disease Testing Market Drivers
Figure 77. Hereditary Disease Testing Market Restraints
Figure 78. Hereditary Disease Testing Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Hereditary Disease Testing Industrial Chain
Figure 81. Methodology
Figure 82. Research Process and Data Source
Figure 1. Hereditary Disease Testing Picture
Figure 2. Global Hereditary Disease Testing Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Hereditary Disease Testing Consumption Value Market Share by Type in 2025
Figure 4. Hereditary Cancer Testing
Figure 5. Hereditary Non-cancer Testing
Figure 6. Global Hereditary Disease Testing Consumption Value by Testing Content, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Hereditary Disease Testing Consumption Value Market Share by Testing Content in 2025
Figure 8. Chromosomal Testing
Figure 9. Gene Mutation Testing
Figure 10. Genome/Exome Sequencing
Figure 11. Carrier Screening Panels
Figure 12. Global Hereditary Disease Testing Consumption Value by Detection Object, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Hereditary Disease Testing Consumption Value Market Share by Detection Object in 2025
Figure 14. Aldult
Figure 15. Child
Figure 16. Global Hereditary Disease Testing Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Hereditary Disease Testing Consumption Value Market Share by Application in 2025
Figure 18. Hospital Picture
Figure 19. Clinic Picture
Figure 20. Laboratory Picture
Figure 21. Others Picture
Figure 22. Global Hereditary Disease Testing Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Hereditary Disease Testing Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Market Hereditary Disease Testing Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 25. Global Hereditary Disease Testing Consumption Value Market Share by Region (2021-2032)
Figure 26. Global Hereditary Disease Testing Consumption Value Market Share by Region in 2025
Figure 27. North America Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 30. South America Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 32. Company Three Recent Developments and Future Plans
Figure 33. Global Hereditary Disease Testing Revenue Share by Players in 2025
Figure 34. Hereditary Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 35. Market Share of Hereditary Disease Testing by Player Revenue in 2025
Figure 36. Top 3 Hereditary Disease Testing Players Market Share in 2025
Figure 37. Top 6 Hereditary Disease Testing Players Market Share in 2025
Figure 38. Global Hereditary Disease Testing Consumption Value Share by Type (2021-2026)
Figure 39. Global Hereditary Disease Testing Market Share Forecast by Type (2027-2032)
Figure 40. Global Hereditary Disease Testing Consumption Value Share by Application (2021-2026)
Figure 41. Global Hereditary Disease Testing Market Share Forecast by Application (2027-2032)
Figure 42. North America Hereditary Disease Testing Consumption Value Market Share by Type (2021-2032)
Figure 43. North America Hereditary Disease Testing Consumption Value Market Share by Application (2021-2032)
Figure 44. North America Hereditary Disease Testing Consumption Value Market Share by Country (2021-2032)
Figure 45. United States Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Hereditary Disease Testing Consumption Value Market Share by Type (2021-2032)
Figure 49. Europe Hereditary Disease Testing Consumption Value Market Share by Application (2021-2032)
Figure 50. Europe Hereditary Disease Testing Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 52. France Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific Hereditary Disease Testing Consumption Value Market Share by Type (2021-2032)
Figure 57. Asia-Pacific Hereditary Disease Testing Consumption Value Market Share by Application (2021-2032)
Figure 58. Asia-Pacific Hereditary Disease Testing Consumption Value Market Share by Region (2021-2032)
Figure 59. China Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 60. Japan Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 61. South Korea Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 62. India Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 63. Southeast Asia Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 64. Australia Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 65. South America Hereditary Disease Testing Consumption Value Market Share by Type (2021-2032)
Figure 66. South America Hereditary Disease Testing Consumption Value Market Share by Application (2021-2032)
Figure 67. South America Hereditary Disease Testing Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa Hereditary Disease Testing Consumption Value Market Share by Type (2021-2032)
Figure 71. Middle East & Africa Hereditary Disease Testing Consumption Value Market Share by Application (2021-2032)
Figure 72. Middle East & Africa Hereditary Disease Testing Consumption Value Market Share by Country (2021-2032)
Figure 73. Turkey Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 74. Saudi Arabia Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 75. UAE Hereditary Disease Testing Consumption Value (2021-2032) & (USD Million)
Figure 76. Hereditary Disease Testing Market Drivers
Figure 77. Hereditary Disease Testing Market Restraints
Figure 78. Hereditary Disease Testing Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Hereditary Disease Testing Industrial Chain
Figure 81. Methodology
Figure 82. Research Process and Data Source
